Projects funded by the NCN
Does short C-terminal peptide of alpha1-antitrypsin modify the susceptibility of PiZZ alpha-1-antitrypsin deficiency carriers to develop lung disease – insight into its biological activity towards human neutrophils.
2018/29/B/NZ5/02346
Keywords:
alpha-1 antitrypsin variants alpha-1 antitrypsin deficiency neutrophils C-terminal peptide COPD lung emphysema
Descriptors:
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Gruźlicy i Chorób Płuc
woj. mazowieckie
Principal investigator (from the host institution):
prof. Joanna Chorostowska-Wynimko
Number of co-investigators in the project: 4
Call: OPUS 15 - announced on 2018-03-15
Amount awarded: 1 529 014 PLN
Project start date (Y-m-d): 2019-01-28
Project end date (Y-m-d): 2024-01-27
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.